Publications by authors named "J F Gavilan"
Objective: This review aims to analyse the implications of the World Health Organization's 2021 world report on hearing, with a particular focus on the cochlear implant field. The objective is to understand the challenges and opportunities highlighted in the report and propose viable solutions for effective implementation within the cochlear implant community.
Methods: Following the release of the World Health Organization's world report on hearing, cochlear implant professionals explored and discussed the implications of the report with examples from various countries to understand the disparities in access, reimbursement policies, and social stigma associated with hearing loss.
Can anatomy-based fitting improve musical perception in adult cochlear implant users?
Braz J Otorhinolaryngol
November 2024
Objectives: To compare Anatomy-Based Fitting (ABF) vs. Default Fitting (DF) in terms of music perception and music enjoyment in CI users.
Methods: CI users ≥ 18 years implanted with a Synchrony ST Flex28 (MEDEL) with at least 12 months of experience with either ABF or DF, with good speech tests outcomes (≥ 65% disyllables) were enrolled.
Article Synopsis
- The study focuses on how otolaryngologists approach testing for congenital sensorineural hearing loss, specifically looking at cCMV infection and genetic testing methods.
- A survey of 20 otolaryngologists showed that 90% use cCMV and genetic tests, with 95% applying cCMV testing in their practices, and many pursue broader genetic screening if initial tests return negative.
- The findings also highlight reimbursement rates for these tests, revealing that a majority of respondents receive coverage for cCMV, genetic variant testing, and wider genetic screening.
Background: While cochlear implantation (CI) and electric acoustic stimulation (EAS) have a positive outcome in most cases, their effectiveness varies depending on the etiology of the hearing loss. Among the various etiologies, genetic factors are the leading cause of hearing loss and may impact CI and EAS outcomes.
Aims/objectives: To reveal the genetic background of the hearing loss in CI/EAS patients in each ethnic population, we undertook a multi-center study involving the genetic testing of hearing loss in CI/EAS patients from 10 centers.
Introduction And Objectives: To identify risk factors associated with the development of hepatocellular carcinoma (HCC) in an unselected cohort of patients with chronic B virus infection (CHB) in Spain. A predictive model was developed to assess the risk of HCC.
Material And Methods: A prospective open-cohort study recruited 446 unselected patients with chronic hepatitis B infection from two hospitals in Málaga (Spain).